In this review:
Fluticasone propionate and antibacterial host defence
E-cigarette vapour effects on S. pneumoniae susceptibility
Burden of lung disease in the UK
Inter-MDT agreement for management in diffuse lung disease
Rituximab in severe, progressive interstitial lung disease
Physicians’ attitudes to dyspnoea management in advanced COPD
Spontaneous pneumothorax and climacteric conditions
Respiratory outcomes post pectus excavatum correction
Pneumothoraces in CT-guided lung biopsies
Usefulness of FEV1/SVC to uncover airflow obstruction
Please login below to download this issue (PDF)